It has been reported that peroxisome proliferator-activated receptor-gamma (PPAR-γ), acting as a nuclear receptor for controlling glucose and lipid metabolism, exerts anti-inflammatory and vasculoprotective effects, making it a potential therapeutic agent in preventing diabetic vascular complications [13,14,15]. Here, PPARG is linked to diabetes mellitus.